| [1] |
International Diabetes Federation. IDF Diabetes Atlas. 7th ed[R]. Brussels: IDF, 2015.
URL
|
| [2] |
Chillarón JJ, Flores Le-Roux JA, Benaiges D, et al. Type 1 diabetes, metabolic syndrome and cardiovascular risk[J]. Metabolism, 2014, 63(2):181-187.
|
| [3] |
Price SA, Gorelik A, Fourlanos S, et al. Obesity is associated with retinopathy and macrovascular disease in type 1 diabetes[J]. Obes Res Clin Pract, 2014, 8(2):e178-e182.
|
| [4] |
Polsky S, Ellis SL. Obesity, insulin resistance, and type 1 diabetes mellitus[J]. Curr Opin Endocrinol Diabetes Obes, 2015, 22(4):277-282.
|
| [5] |
Franck M, Paquot N, Scheen AJ. Influence of body weight on the natural history of and the therapeutic approaches to type 1 diabetes[J]. Rev Med Liege, 2012, 67(9):461-467.
|
| [6] |
Burchardt P, Zawada A, Tabaczewski P, et al. Metformin added to intensive insulin therapy reduces plasma levels of glycated but not oxidized low density lipoprotein in young patients with type 1 diabetes and obesity in comparison with insulin alone: a pilot study[J]. Pol Arch Med Wewn, 2013, 123(10):526-532.
|
| [7] |
Sarkar G, Alattar M, Brown RJ, et al. Exenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetes[J]. Diabetes Care, 2014, 37(10):666-670.
|
| [8] |
Perkins BA, Cherney DZ, Partridge H, et al. Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial[J]. Diabetes Care, 2014, 37(5):1480-1483.
|
| [9] |
Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis[J]. Am J Med, 2009, 122(3):248-256.
|
| [10] |
Kirwan JP, Aminian A, Sangeeta R, et al. Bariatric surgery in obese patients with type 1 diabetes[J]. Diabetes Care, 2016, 39(6):941-948.
|
| [11] |
Robert M, Belanger P, Hould FS, et al. Should metabolic surgery be offered in morbidly obese patients with type I diabetes?[J]. Surg Obes Relat Dis, 2015, 11(4):798-805.
|
| [12] |
Maraka S, Kudva YC, Kellogg TA, et al. Bariatric surgery and diabetes: Implications of type 1 versus insulin-requiring type 2[J]. Obesity (Silver Spring), 2015, 23(3):552-557.
|
| [13] |
Middelbeek RJ, James-Todd T, Cavallerano JD, et al. Gastric bypass surgery in severely obese women with type 1 diabetes: Anthropometric and cardiometabolic effects at 1 and 5 years postsurgery[J]. Diabetes Care, 2015, 38(7):e104-e105.
|
| [14] |
Lannoo M, Dillemans B, Van Nieuwenhove Y, et al. Bariatric surgery induces weight loss but does not improve glycemic control in patients with type 1 diabetes[J]. Diabetes Care, 2014, 37(8):e173-e174.
|
| [15] |
Brethauer SA, Aminian A, Rosenthal RJ, et al. Bariatric surgery improves the metabolic profile of morbidly obese patients with type 1 diabetes[J]. Diabetes Care, 2014, 37(3):e51-e52.
|
| [16] |
Blanco J, Jiménez A, Casamitjana R, et al. Relevance of beta-cell function for improved glycemic control after gastric bypass surgery[J]. Surg Obes Relat Dis, 2014, 10(1):9-13.
|
| [17] |
Tang A, Milner K-L, Tonks K, et al. Comment on Brethauer et al. Bariatric surgery improves the metabolic profile of morbidly obese patients with type 1 diabetes[J]. Diabetes Care, 2014, 37(11):e51-e52.
|
| [18] |
Raab H, Weiner RA, Frenken M, et al. Obesity and metabolic surgery in type 1 diabetes mellitus[J]. Nutr Hosp, 2013, 28(Suppl2):31-34.
|
| [19] |
Garciacaballero M, Martínez-Moreno JM, Toval JA, et al. Improvement of C peptide zero BMI 24-34 diabetic patients after tailored one anastomosis gastric bypass (BAGUA)[J]. Nutr Hosp, 2013, 28(Suppl 2):35-46.
|
| [20] |
Smith BR, Hinojosa MW, Reavis KM, et al. Remission of diabetes after laparoscopic gastric bypass[J]. Am Surg, 2008(74):948-952.
|
| [21] |
Ashrafian H, Harling L, Toma T, et al. Type 1 diatetes mellitus and bariatric surgery: A systematic review and meta- analysis[J]. Obes surg, 2016, 26(8):1697-1704.
|
| [22] |
Fuertes-Zamorano N, Sánchez-Pernaute A, Torres García AJ, et al. Bariatric surgery in type 1 diabetes mellitus; long-term experience in two cases[J]. Nutr Hosp, 2013, 28(4):1333-1336.
|
| [23] |
Cohen R. Comment on: should metabolic surgery be offered in morbidly obese patients with type I diabetes?[J]. Surg Obes Relat Dis, 2015, 11(4):805-807.
|
| [24] |
Schauer PR, Bhatt DL, Kirwan JP, et al. STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes[J]. N Engl J Med, 2014, 370(21):2002-2013.
|
| [25] |
Aminian A, Brethauer SA, Kirwan JP, et al. How safe is metabolic/diabetes surgery?[J]. Diabetes Obes Metab, 2015, 17(2):198-201.
|
| [26] |
Czupryniak L, Wiszniewski M, Szymański D, et al. Long-term results of gastric bypass surgery in morbidly obese type 1 diabetes patients[J]. Obes Surg, 2010, 20(4):506-508.
|
| [27] |
Chuang J, Zeller MH, Inge T, et al. Bariatric surgery for severe obesity in two adolescents with type 1 diabetes[J]. Pediatrics, 2013, 132(4):e1031-e1034.
|
| [28] |
Middelbeek RJ, James-Todd T, Patti ME, et al. Short-term insulin requirements following gastric bypass surgery in severely obese women with type 1 diabetes[J]. Obes Surg, 2014, 24(9):1442-1446.
|
| [29] |
Aminian A, Kashyap SR, Burguera B, et al. The incidence and clinical features of diabetic ketoacidosis after bariatric and metabolic surgery[J]. Diabetes Care, 2016, 39(4):e50-e53.
|
| [30] |
Han SH, White S, Patel K, et al. Acute gastric remnant dilation after laparoscopic Roux-en-Y gastric bypass operation in long-standing type I diabetic patient: case report and literature review[J]. Surg Obes Relat Dis, 2006, 2(6):664-666.
|
| [31] |
Lindqvist A, Spégel P, Ekelund M, et al. Gastric bypass improves β-cell function and increases β-cell mass in a porcine model[J]. Diabetes, 2014, 63(5):1665-1671.
|
| [32] |
Zhang S, Zhang Q, Zhang L, et al. Expression of ghrelin and leptin during the development of type 2 diabetes mellitus in a rat model[J]. Mol Med Rep, 2013, 7(1):223-228.
|
| [33] |
Air EL, Benoit SC, Clegg DJ, et al. Insulin and leptin combine additively to reduce food intake and body weight in rats[J]. Endocrinology, 2002, 143(6):2449-2452．
|
| [34] |
Edwards C, Hindle AK, Fu S, et al. Downregulation of leptin and resistin expression in blood following bariatric surgery[J]. Surg Endosc, 2011, 25(6):1962-1968.
|
| [35] |
Palikhe G, Gupta R, Behera BN, et al. Efficacy of laparoscopic sleeve gastrectomy and intensive medical management in obese patients with type 2 diabetes mellitus[J]. 0bes surg, 2014, 24(4):529-535
|
| [36] |
Shoelson SE, Herrero L, Naaz A. 0besity，inflammation，and insulin resistance[J]. Gastroenterology, 2007, 132(6):2169-2180.
|
| [37] |
Hu C, Su Q，Li F，et al．Duodenal-Jejunal bypass improves glucose homeostasis in association with decreased proinflammatory response and activation of JNK in the liver and adipose tissue in a T2DM rat model[J]. Obes Surg, 2014, 24(9):1453-1462.
|
| [38] |
Illan-Gomez F, Gonzalvez-Ortega M, Orea-Soler I, et al. Obesity and inflammation：change in adiponectin, C-reactive protein,tumour necrosis factor-alpha and interleukin-6 after bariatric surgery[J]. Obes Surg, 2012, 22(6):950-955.
|
| [39] |
Mallipedhi A, Prior S L, Barry JD, et al. Changes in inflammatory markers after sleeve gastrectomy in patients with impaired glucose homeostasis and type 2 diabetes[J]. Surg Obes Relat Dis, 2014, 10(6):1123-1128.
|
| [40] |
Aminian A, Jamal M, Augustin T, et al. Failed surgical weight loss does not necessarily mean failed metabolic effects[J]. Diabetes Technol Ther, 2015, 17(10):682-684.
|
| [41] |
Dirksen C, Jacobsen SH, Bojsen-Møller KN, et al. Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes: a case report[J]. Obes Res Clin Pract, 2013, 7(4):e269-e274.
|
| [42] |
Kielgast U, Krarup T, Holst JJ, et al. Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function[J]. Diabetes Care, 2011, 34(7):1463-1468.
|
| [43] |
Breen DM, Rasmussen BA, Kokorovic A, et al. Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes[J]. Nat Med, 2012, 18(6):950-955.
|
| [44] |
Simonen M, Dali-Youcef N, Kaminska D, et al. Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass[J]. Obes Surg, 2012, 22(9):1473-1480.
|
| [45] |
刘光耀，王群伟，刘威. 胆汁酸与减重手术[J]. 中华胃肠外科杂志, 2015, 18(5):516-520.
|